ResMed Inc. ($RMD) Stock Forecast: Down 5.8% Today

What is ResMed Inc.?

ResMed Inc. (RMD) specializes in medical equipment, particularly in the field of sleep apnea and respiratory disorders. The market has shown recent bullish trends, especially within the healthcare and technology sectors.

Why is ResMed Inc. going down?

RMD stock is down 5.8% on Jan 31, 2025 17:40

• ResMed (RMD) reported strong Q2 earnings and revenue surpassing expectations, but the stock faced a bearish trend.
• The stock's decline post-achieving a 52-week high could be attributed to profit-taking, causing a temporary decrease in price.
• Some investors are uncertain about the sustainability of ResMed's growth, leading them to sell shares despite positive financial performance.
• The bearish movement might also stem from broader market shifts or sector rotations, with investors temporarily diverting attention from healthcare stocks.

RMD Price Chart

RMD Technical Analysis

RMD News

ResMed Inc. ( RMD ) Hits Fresh High: Is There Still Room to Run?

ResMed (RMD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

https://www.zacks.com/stock/news/2407449/resmed-inc-rmd-hits-fresh-high-is-there-still-room-to-run

ResMed Q2 Earnings and Revenues Beat, Stock Up in Pre-Market

RMD's stellar second-quarter fiscal 2025 results reflect the ongoing momentum and strong execution across all areas of its business.

https://www.zacks.com/stock/news/2407443/resmed-q2-earnings-and-revenues-beat-stock-up-in-pre-market

ResMed ( RMD ) Tops Q2 Earnings and Revenue Estimates

ResMed (RMD) delivered earnings and revenue surprises of 5.65% and 1.57%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2407028/resmed-rmd-tops-q2-earnings-and-revenue-estimates

Trending Today

Cardano ($ADA) Crypto Forecast: Up 5.7% Today

Arkham ($ARKM) Crypto Forecast: Up 5.5% Today

Memecoin ($MEME) Crypto Forecast: Up 5.3% Today

The Graph ($GRT) Crypto Forecast: Up 5.3% Today

Internet Computer ($ICP) Crypto Forecast: Up 5.1% Today

MANTRA ($OM) Crypto Forecast: Up 6.8% Today

Bittensor ($TAO) Crypto Forecast: Up 9.9% Today

Notcoin ($NOT) Crypto Forecast: Up 5.2% Today

Hasbro Inc. ($HAS) Stock Forecast: Up 13.0% Today

Walmart Inc. ($WMT) Stock Forecast: Down 5.9% Today

ResMed Inc. Price History

27.07.2024 - RMD Stock was up 5.0%

• ResMed's stock surged by 12% in the quarter, reflecting strong investor confidence in the company's growth prospects.
• Positive outlook from William Blair further boosted investor sentiment towards ResMed, indicating a favorable future trajectory for the stock.
• Despite an executive selling shares worth over $200k, the overall market sentiment remained positive, suggesting that investors were not significantly deterred by the insider selling.
• ResMed's consistent outperformance over the past decade, with an average annual return of 15.63%, has solidified its position as a strong investment choice, attracting more investors to the stock.

25.09.2024 - RMD Stock was up 6.1%

• ResMed's strong Q1 financial results, fueled by growing demand for its sleep devices and masks, have driven a positive trend in its stock.
• The company's solid overall performance, evident in improved margins and surpassing financial projections, has instilled confidence among investors.
• Analysts consider ResMed a resilient player in the medical technology industry, underpinned by strong fundamentals, which likely attracted more investors and contributed to the upward movement in the market.

27.07.2024 - RMD Stock was up 5.8%

• The bullish movement in ResMed's stock today could be attributed to the positive long-term performance, where it outperformed the market by 4.82% annually over the past decade.
• The news of an executive selling shares worth over $200k might have initially raised concerns, but the overall market sentiment seems to have been unaffected, possibly due to the company's solid fundamentals and growth prospects.
• Investors may be optimistic about ResMed's future potential, considering its current market capitalization of $32.71 billion, indicating confidence in the company's ability to deliver sustained growth and value to shareholders.

25.09.2024 - RMD Stock was up 5.9%

• ResMed (RMD) experienced a strong bullish movement today following the release of its Q1 earnings.
• The company surpassed both earnings and revenue estimates, indicating strong financial performance and market confidence.
• Investors likely responded positively to the results, showing optimism about ResMed's growth potential and ability to deliver consistent value to shareholders.
• The market movement could be attributed to the market's favorable reaction to ResMed's solid performance and optimistic outlook for future growth.

31.00.2025 - RMD Stock was down 5.8%

• ResMed (RMD) reported strong Q2 earnings and revenue surpassing expectations, but the stock faced a bearish trend.
• The stock's decline post-achieving a 52-week high could be attributed to profit-taking, causing a temporary decrease in price.
• Some investors are uncertain about the sustainability of ResMed's growth, leading them to sell shares despite positive financial performance.
• The bearish movement might also stem from broader market shifts or sector rotations, with investors temporarily diverting attention from healthcare stocks.

31.00.2025 - RMD Stock was down 8.3%

• Despite beating Q2 earnings and revenue estimates, the stock experienced a bearish movement.
• Investors might have been expecting even higher earnings and revenue figures, leading to a sell-off after the announcement.
• The market may have reacted negatively to guidance or other forward-looking statements made by the company's management during the earnings call.
• Overall market conditions or external factors could have influenced the bearish sentiment towards ResMed (RMD) despite its positive financial performance.

24.05.2024 - RMD Stock was down 5.2%

• ResMed stock experienced a significant decline due to the negative impact of Eli Lilly's weight-loss drug on sleep apnea events, leading to investor concerns and selling pressure.
• A downgrade by Citi and reduction in stock target contributed to the bearish sentiment surrounding ResMed.
• The market was also influenced by Nvidia's third consecutive day of decline, leading to overall cautiousness among investors.
• Collaboration talks between ByteDance and Broadcom on an AI superprocessor may have diverted attention from traditional healthcare stocks like ResMed, impacting its performance negatively.

24.05.2024 - RMD Stock was down 5.0%

• ResMed shares fell sharply by 10.4% following the release of clinical trial results by another company showing the effectiveness of its weight-loss drug in reducing sleep apnea events.
• A financial analyst downgraded ResMed from Buy to Neutral, adding to the negative sentiment surrounding the stock.
• The news of a potential impact on ResMed's sales due to the efficacy of the weight-loss drug in treating sleep apnea likely contributed to the bearish movement in the stock.
• This event highlights the vulnerability of healthcare companies to developments in clinical trials and the competitive landscape, leading to significant market reactions.

21.05.2024 - RMD Stock was down 5.3%

• ResMed (RMD) stock moved downward despite the industry's positive growth trajectory.
• Factors like reduced demand for COVID-19-related products and financial restrictions in U.S. healthcare facilities could have influenced ResMed's revenue negatively.
• Supply chain limitations, higher material expenses, and workforce shortages in specific regions may have added to ResMed's challenges.
• While ResMed has historically outperformed the market, its stock price could have been impacted by the persistent obstacles and margin pressures outlined in the assessments.

26.06.2024 - RMD Stock was down 5.3%

• The downtrend in ResMed's stock today may be linked to concerns about the forthcoming earnings report, with expectations of limited earnings growth from Wall Street.
• While high-profile investors have been expressing optimism about ResMed, overall market sentiment appears cautious, leading to a potential stock sell-off.
• Variation in predictions between retail traders and Wall Street analysts regarding ResMed's earnings performance could be contributing to investor uncertainty, influencing today's bearish market activity.

26.06.2024 - RMD Stock was down 6.4%

• Despite historical market outperformance, ResMed (RMD) experienced a bearish movement today.
• High-rolling investors' bullish positioning in ResMed's options did not boost market sentiment.
• Uncertainty surrounding the upcoming earnings report may have led to the stock sell-off.
• Profit-taking by long-term investors with substantial gains in ResMed could have influenced today's bearish movement.

02.07.2024 - RMD Stock was up 5.3%

• Q4 earnings for ResMed exceeded estimates, with adjusted EPS up by 30% year over year, showcasing strong financial performance.
• Increased demand for sleep devices and masks led to revenue growth and improved margins, supported by cost efficiencies and a favorable product mix.
• CEO's confidence in addressing investor concerns about weight-loss drugs impacting sales further boosted investor sentiment, contributing to the stock's bullish movement.
• ResMed's robust financials, positive market dynamics, and management's strategic reassurances likely fueled the day's bullish momentum in the stock.